Evidence map›Paper›PMID 37959796›Full record

ArticleMolecules (Basel, Switzerland)2023

Selected

Xiuyi Liang, Agata J Pacuła-Miszewska, Magdalena Obieziurska-Fabisiak, Richa Vartak, Ganming Mao, Ketankumar Patel, Natalya U Fedosova, Jacek Ścianowski, Blase Billack

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. 3D human epithelial models: a promising platform for studyingFrontiers in cellular and infection microbiology · 2025
    Article
  2. Current issues in molecular biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Xiuyi LiangDepartment of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.
Agata J Pacuła-MiszewskaFaculty of Chemistry, Nicolaus Copernicus University, 87-100 Toruń, Poland.ORCID 0000-0001-7619-9288
Magdalena Obieziurska-FabisiakFaculty of Chemistry, Nicolaus Copernicus University, 87-100 Toruń, Poland.
Richa VartakDepartment of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.
Ganming MaoDepartment of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.
Ketankumar PatelDepartment of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.ORCID 0000-0001-8252-0234
Natalya U FedosovaDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-1706-6108
Jacek ŚcianowskiFaculty of Chemistry, Nicolaus Copernicus University, 87-100 Toruń, Poland.ORCID 0000-0002-3868-2022
Blase BillackDepartment of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.ORCID 0000-0001-7180-5955
St. John's University · USNicolaus Copernicus University · PLAarhus University · DK

Funding

Dermal-Epidermal Junction Disruptors: Mechanistic InsightsSC2GM136612 · NIGMS · ST. JOHN'S UNIVERSITY · PI BILLACK, BLASE CHRISTOPHER · 2020 to 2022
$369k
NIGMS NIH HHS SC2 GM136612
6 · The paper itself

Abstract

In the present work, a series of

Indexed as

Candidiasis, VulvovaginalAntifungal AgentsCandida albicansFemaleFluconazoleHumansMicrobial Sensitivity TestsVaginaAntifungal AgentsFluconazoleantifungal activityCandida albicansCandida resistant strainsN-terpenyl organoseleniumvulvovaginal candidiasis

Identifiers

PMID37959796
PMCPMC10647704
OpenAlexW4388078684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.